Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.35 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.34 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 3/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17657671 | 0.99 | AHR (0.41) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL17118367 | 0.97 | AHR (0.40) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL17118383 | 0.97 | AHR (0.40) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL17118379 | 0.97 | AHR (0.40) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL17657669 | 0.96 | MMP12 (0.40) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL21907419 | 0.96 | AHR (0.42) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL17657661 | 0.95 | AHR (0.38) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL26525259 | 0.95 | MMP12 (0.40) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL26525220 | 0.95 | MMP12 (0.40) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL17657672 | 0.95 | MMP12 (0.40) | AHRMEN1MAPTKMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11316125-B2 | Organic light-emitting device and display apparatus including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-04-26 | — | — | US | disclosed |
| US-11165029-B2 | Amine compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-02 | — | — | US | disclosed |
| US-20200111986-A1 | ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-09 | — | — | US | disclosed |
| US-20180083209-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
| US-20180083209-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180083209-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | PNMT, PIEZO1, ODC1 | AHR 1138/4885MEN1 178/4885MAPT 1266/4885 |
| US-11165029-B2 | Amine compound and organic electroluminescence device including the same | PNMT, PIEZO1, ODC1 | AHR 1138/4885MEN1 178/4885MAPT 1266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.